Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Moxibustion for cancer care: a systematic review and meta-analysis

Authors: Myeong Soo Lee, Tae-Young Choi, Ji-Eun Park, Song-Shil Lee, Edzard Ernst

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Moxibustion is a traditional Chinese method that uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulate acupuncture points. Considering moxibustion is closely related to acupuncture, it seems pertinent to evaluate the effectiveness of moxibustion as a treatment of symptoms of cancer. The objective of this review was to systematically assess the effectiveness of moxibustion for supportive cancer care.

Methods

We searched the literature using 11 databases from their inceptions to February 2010, without language restrictions. We included randomised clinical trials (RCTs) in which moxibustion was employed as an adjuvant treatment for conventional medicine in patients with any type of cancer. The selection of studies, data extraction, and validations were performed independently by two reviewers.

Results

Five RCTs compared the effects of moxibustion with conventional therapy. Four RCTs failed to show favourable effects of moxibustion for response rate compared with chemotherapy (n = 229, RR, 1.04, 95% CI 0.94 to 1.15, P = 0.43). Two RCTs assessed the occurrence of side effects of chemotherapy and showed favourable effects of moxibustion. A meta-analysis showed significant less frequency of nausea and vomiting from chemotherapy for moxibustion group (n = 80, RR, 0.38, 95% CIs 0.22 to 0.65, P = 0.0005, heterogeneity: χ2 = 0.18, P = 0.67, I2 = 0%).

Conclusion

The evidence is limited to suggest moxibustion is an effective supportive cancer care in nausea and vomiting. However, all studies have a high risk of bias so effectively there is not enough evidence to draw any conclusion. Further research is required to investigate whether there are specific benefits of moxibustion for supportive cancer care.
Appendix
Available only for authorised users
Literature
1.
Wong R, Sagar CM, Sagar SM: Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition. Cancer Treat Rev. 2001, 27: 235-246. 10.1053/ctrv.2001.0227.CrossRefPubMed
2.
3.
Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, Adjei AA: Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004, 22: 4810-4815. 10.1200/JCO.2004.03.121.CrossRefPubMed
4.
Frenkel M, Ben-Arye E, Baldwin CD, Sierpina V: Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J. 2005, 98: 289-294. 10.1097/01.SMJ.0000154776.71057.E8.CrossRefPubMed
5.
Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000, 18: 2505-2514.PubMed
6.
7.
Ernst E: Acupuncture--a critical analysis. J Intern Med. 2006, 259: 125-137. 10.1111/j.1365-2796.2005.01584.x.CrossRefPubMed
8.
Deng G, Vickers A, Simon Yeung K, Cassileth BR: Acupuncture: integration into cancer care. J Soc Integr Oncol. 2006, 4: 86-92.PubMed
9.
Ernst E, Pittler M, Wider B, Boddy K: Oxford Handbook of Complementary Medicine. 2008, Oxford, UK: Oxford University PressCrossRef
10.
Lao L: Acupuncture practice, past and present: is it safe and effective?. J Soc Integr Oncol. 2006, 4: 13-15.PubMed
11.
World Health Organization Western Pacific Region: WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region. 2007, Manila, Philippine: World Health Organization Western Pacific, 251-254.
12.
Chen ZJ, Guo YP, Wu ZC: Advances of clinical study on acupuncture and moxibustion for treatment of cancer pain. Chin Acupunct Moxibustion. 2008, 28: 392-394.
13.
Kim SY, Chae Y, Lee SM, Lee H, Park HJ: The effectiveness of moxibustion: an overview during 10 years. Evid Based Complement Alternat Med. 2009
14.
Kuai L, Chen H, Yang HY: Current status and prospect of acupuncture-moxibustion in treatment of cancer pain: a review. Zhong Xi Yi Jie He Xue Bao. 2008, 6: 197-202. 10.3736/jcim20080219.CrossRefPubMed
15.
Shen QP, Tian HQ: Acupuncture-moxibustion in treatment of cancer pain:a review. Henan Tradit Chin Med. 2008, 28: 84-86.
16.
Zhang JL, Li SS, Luo WH, Zhang DF, Shu RG: Research of moxibustion therapy for cancer:a review. Jiangxi J Tradit Chin Med. 2008, 39: 59-61.
17.
Higgins JPT, Altman DG: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Edited by: Higgins JPT, Green S. 2008, West Sussex, England: Wiley-Blackwell, 187-241. full_text.CrossRef
18.
Cheng Z, Jiang Y, Chen K: Radiochemical and chemotherapy therapy with Shenque Point moxibustion treatment of 42 cases of advanced nasopharyngeal carcinoma. New J Tradit Chin Med. 2005, 37: 58-59.
19.
Chen K, Jiang Y, Wen H, Lu XZ, Lu L, Wang H, Huang GZ: Clinical study on treatment of nasopharyngeal carcinoma by radio and chemotherapy with supplementary moxibustion on Shenque point. Chin J Integ Med. 2000, 20: 733-735.
20.
Cao JX, Xiao XH, Tang XY: Elemene fluorouracil Moxibustion "Shenque" effect in the treatment of advanced gastric cancer observed. Chin J Clin Oncol. 1997, 24: 549-550.
21.
Liu J, Yu RC, Rao XQ: Study on Effect of Moxibustion and Guben Yiliu ¥2 Combined with Chemotherapy in Treating Middle-Late Stage Malignant Tumor. Chin J Integr Tradit West Med. 2001, 21: 262-264.
22.
Bian D, Cheng ZD, Zhang NS, et al: Effects of Acupoint-injection plus moxibustion on IL-2/IL-2R expression in peripheral blood in the patient with carcinous pain. Chin Acupunct Moxibustion. 2004, 24: 641-644.
23.
Deng H, Long SQ, Wu WY, et al: Prevention and treatment of leucopenia due to chemotherapy by moxibustion:A clinical observation of 46 cases. J New Chin Med. 2007, 39: 90-91.
24.
Huang XM: Acupuncture and moxa cone moxibustion treatment of chemotherapy-induced diarrhea in 70 cases. Henan Tradit Chin Med. 1996, 16: 173-
25.
Huang XM, Chen HL, Guo XM, Ma YM: Treatment with cone moxibustion of chemotherapeutic leucocytopenia in 114 cases. J Tradit Chin Med. 1993, 13: 266-267.PubMed
26.
Wang CP: Ginger-partitioned moxibustion back yu point for treatment of luekopenia induced by chemotherapy clinical observation of 40 cases. Hebei J radit Chin Med. 2008, 30: 412-
27.
Wang LS, Wang LZ, Chen YR: Ginger-partitioned moxibustion treatment of chemotherapy response in patients with gastrointestinal Clinical observation and nursing care. Chin J Nurs. 1990, 335-336.
28.
Yao X, Miao N: Effect of ginger-partition moxibustion combining acupoint injection to chemotherapy-vomit. Jilin Med J. 2007, 28: 1681-1682.
29.
Zhai DD, Chen HP, Wang RZ, Ding BY: Moxibustion directly regulate cellular immune function in patients with cancer of the observation. J Cliin Acupunct Moxibustion. 1994, 10: 25-27.
30.
Guittier MJ, Klein TJ, Dong H, Andreoli N, Irion O, Boulvain M: Side-effects of moxibustion for cephalic version of breech presentation. J Altern Complement Med. 2008, 14: 1231-1233. 10.1089/acm.2008.0134.CrossRefPubMed
31.
Wheeler J, Coppock B, Chen C: Does the burning of moxa (Artemisia vulgaris) in traditional Chinese medicine constitute a health hazard?. Acupunct Med. 2009, 27: 16-20. 10.1136/aim.2009.000422.CrossRefPubMed
32.
Yamashita H, Tsukayama H, Tanno Y, Nishijo K: Adverse events in acupuncture and moxibustion treatment: a six-year survey at a national clinic in Japan. J Altern Complement Med. 1999, 5: 229-236. 10.1089/acm.1999.5.229.CrossRefPubMed
33.
Hui KK, Liu J, Makris N, Gollub RL, Chen AJ, Moore CI, Kennedy DN, Rosen BR, Kwong KK: Acupuncture modulates the limbic system and subcortical gray structures of the human brain: evidence from fMRI studies in normal subjects. Hum Brain Mapp. 2000, 9: 13-25. 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F.CrossRefPubMed
34.
Hui KK, Liu J, Marina O, Napadow V, Haselgrove C, Kwong KK, Kennedy DN, Makris N: The integrated response of the human cerebro-cerebellar and limbic systems to acupuncture stimulation at ST 36 as evidenced by fMRI. Neuroimage. 2005, 27: 479-496. 10.1016/j.neuroimage.2005.04.037.CrossRefPubMed
35.
Lu W, Dean-Clower E, Doherty-Gilman A, Rosenthal DS: The value of acupuncture in cancer care. Hematol Oncol Clin North Am. 2008, 22: 631-648. 10.1016/j.hoc.2008.04.005.CrossRefPubMedPubMedCentral
36.
Napadow V, Ahn A, Longhurst J, Lao L, Stener-Victorin E, Harris R, Langevin HM: The status and future of acupuncture mechanism research. J Altern Complement Med. 2008, 14: 861-869. 10.1089/acm.2008.SAR-3.CrossRefPubMedPubMedCentral
37.
Napadow V, Makris N, Liu J, Kettner NW, Kwong KK, Hui KK: Effects of electroacupuncture versus manual acupuncture on the human brain as measured by fMRI. Hum Brain Mapp. 2005, 24: 193-205. 10.1002/hbm.20081.CrossRefPubMed
38.
Han JS: Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci. 2003, 26: 17-22. 10.1016/S0166-2236(02)00006-1.CrossRefPubMed
39.
Dhond RP, Kettner N, Napadow V: Neuroimaging acupuncture effects in the human brain. J Altern Complement Med. 2007, 13: 603-616. 10.1089/acm.2007.7040.CrossRefPubMed
40.
41.
Yi SX, Peng Y, Chang XR, Peng N, Yan J, Lin YP: Effect of pre-moxibustion on apoptosis and proliferation of gastric mucosa cells. World J Gastroenterol. 2007, 13: 2174-2178.CrossRefPubMedPubMedCentral
42.
Zhang ZI, Chen JI, Zhu SL: Endorphin mechanism of the regulating effect of direct moxibustion on immunity. Shanghai J Acupunct Moxibustion. 13: 223-224.
43.
Pei J: Effect of moxibustion of dazhui (GV-14) on cellular immune function in tumor-bearing mice. Int J Orient Med. 1995, 20: 72-76.
44.
Qiu X, Chen K, Tong L, Shu X, Lu X, Wen H, Deng C: Effects of moxibustion at shenque (CV 8) on serum IL-12 level and NK cell activities in mice with transplanted tumor. J Tradit Chin Med. 2004, 24: 56-58.PubMed
45.
Mullen PD, Ramirez G: The promise and pitfalls of systematic reviews. Annu Rev Public Health. 2006, 27: 81-102. 10.1146/annurev.publhealth.27.021405.102239.CrossRefPubMed
46.
Linde K, Willich SN: How objective are systematic reviews? Differences between reviews on complementary medicine. J R Soc Med. 2003, 96: 17-22. 10.1258/jrsm.96.1.17.CrossRefPubMedPubMedCentral
47.
Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions. 2008, West Sussex, England: Wiley-BlackwellCrossRef
48.
49.
Pittler MH, Abbot NC, Harkness EF, Ernst E: Location bias in controlled clinical trials of complementary/alternative therapies. J Clin Epidemiol. 2000, 53: 485-489. 10.1016/S0895-4356(99)00220-6.CrossRefPubMed
50.
Rothstein HR, Sutton AJ, Borenstein M: Publication bias in meta-analysis. Publication bias in meta-analysis. Edited by: Rothstein HR, Sutton AJ, Borenstein M. 2005, Chichester, West Sussex: WileyCrossRef
51.
Vickers A, Goyal N, Harland R, Rees R: Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials. 1998, 19: 159-166. 10.1016/S0197-2456(97)00150-5.CrossRefPubMed
Metadata
Title
Moxibustion for cancer care: a systematic review and meta-analysis
Authors
Myeong Soo Lee
Tae-Young Choi
Ji-Eun Park
Song-Shil Lee
Edzard Ernst
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-130

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue

Research article

Physical activity interventions to improve daily walking activity in cancer survivors

Research article

Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial

Research article

A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes

Research article

Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma

Research article

Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study

Research article

Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits